Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Beneth Capital LLC reported a 9.30% stake in Lixte Biotechnology Holdings, Inc. (Schedule 13G)
Event Nov 6, 2026 · Filed Nov 16, 2026
Beneth Capital LLC reported a 9.30% stake in Lixte Biotechnology Holdings, Inc., 1,494,641 shares, as a passive investor on Nov 6, 2026. Filed Nov 16, 2026 (Schedule 13G).
- Stake
- 9.30%
- Shares
- 1,494,641
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Beneth Capital LLC | 9.30% | 1,494,641 |
| Meghan Ciccarelli | 9.30% | 1,494,641 |
Source
Download original · View original at SEC
Related
- Lixte Biotechnology Holdings, Inc.
- Beneth Capital LLC
- Lixte Biotechnology Holdings, Inc. shareholders
- Schedule 13G · Geordan Pursglove · Nov 16, 2026
- Schedule 13G · North York Ltd · Oct 28, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026